Applicant, as named in the Orange Book

Galderma Labs Lp

Next listed expiry: Oracea on 19 Dec 2027. 4 products with live protection, 11 without.

Products with listed protection

DrugEarliest generic entry
Oracea
doxycycline
19 Dec 2027
Mirvaso
brimonidine tartrate
13 Jun 2031
Aklief
trifarotene
30 May 2033
Soolantra
ivermectin
13 Mar 2034

Recent events

  • Metrogel · Generic approved · ANDA 220095, Zydus LifesciencesApproved 13 Feb 2026Detected 25 Oct 2026
  • Differin · Generic approved · ANDA 219565, RisingApproved 30 Jun 2026Detected 25 Oct 2026
  • Epiduo · Enters 12-month window basis: patentListed date 18 Jul 2027Detected 24 Oct 2026
Products without listed protection (11)
DrugEarliest generic entry
Clobex
clobetasol propionate
open now
Clobex
clobetasol propionate
open now
Differin
adapalene
open now
Differin
adapalene
open now
Differin
adapalene
open now
Differin Epiduo
adapalene; benzoyl peroxide
open now
Metrocream
metronidazole
open now
Metrogel
metronidazole
open now
Metrolotion
metronidazole
open now
Tri-Luma
fluocinolone acetonide; hydroquinone; tretinoin
open now
Vectical
calcitriol
open now